IL13RA2 and cancer: Therefore, the potential of IL‐13Rα2 for use in receptor‐directed cancer therapy has been suggested.[130] Pep‐1, a linear homing peptide with an amino acid sequence of CGEMGWVRC, can penetrate the BTB via IL‐13Rα2‐mediated endocytosis.